THE CAMPAIGN FOR SUSTAINABLE RX PRICING

Lobbying client · District of Columbia · filed 2025 to 2026

A coalition of organizations working on market-based solutions to drug pricing.

$630,000 Reported spend

7 Filings counted

1 Outside firm hired

30 Bills named

Spend is reported income plus in-house expenses across 7 filings. Everything on this page comes from one LDA client record (175642), filed by the registrant listed below.

Who filed for this client 1

MEHLMAN CONSULTING, INC. $630,000 Outside firm · 7 filings

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

Bills named in these filings 30

H.R. 1843
To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

7 filings
S. 1040
Drug Competition Enhancement Act

7 filings
S. 1041
Affordable Prescriptions for Patients Act

7 filings
S. 1095
Stop STALLING Act

7 filings
S. 1096
Preserve Access to Affordable Generics and Biosimilars Act

7 filings
S. 1097
Interagency Patent Coordination and Improvement Act of 2025

7 filings
S. 229
DTC Act of 2025

7 filings
S. 43
Skinny Labels, Big Savings Act

7 filings
H.R. 3269
ETHIC Act

6 filings
H.R. 3789
DTC Act of 2025

6 filings
S. 1954
Biosimilar Red Tape Elimination Act

6 filings
S. 2276
ETHIC Act

6 filings
H.R. 3010
No Handouts for Drug Advertisements Act

5 filings
H.R. 3152
Patent Eligibility Restoration Act of 2025

5 filings
H.R. 3160
PREVAIL Act

5 filings
S. 1032
Major Richard Star Act

5 filings
S. 1533
A bill to amend title 38, United States Code, to make permanent and codify the pilot program for use of contr…

5 filings
S. 1546
Patent Eligibility Restoration Act of 2025

5 filings
S. 1785
No Handouts for Drug Advertisements Act

5 filings
S. 2630
Saving NSF’s Workforce Act

5 filings
H.R. 1262
Mikaela Naylon Give Kids a Chance Act

4 filings
H.R. 4570
Interagency Patent Coordination and Improvement Act of 2025

3 filings
H.R. 5526
Biosimilar Red Tape Elimination Act

3 filings
H.R. 6485
Skinny Labels, Big Savings Act

3 filings
S. 1414
Expedited Access to Biosimilars Act

3 filings
S. 3014
Ensuring Timely Access to Generics Act of 2025

3 filings
S. 1067
Ensuring Timely Access to Generics Act of 2023

2 filings
H.R. 1
One Big Beautiful Bill Act

2 filings
S. 1302
Increasing Transparency in Generic Drug Applications Act

2 filings
S. 2658
Medication Affordability and Patent Integrity Act

2 filings

Reported by year 2 years

2026 $270,000 3 filings
2025 $360,000 4 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 5

HOUSE OF REPRESENTATIVES 7
SENATE 7
Centers For Medicare and Medicaid Services (CMS) 6
Health & Human Services, Dept of (HHS) 6
Food & Drug Administration (FDA) 3

Recent filings 7 total

Q3 report

MEHLMAN CONSULTING, INC.

3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $90,000 income · posted Oct 20, 2026

View → Q2 report

MEHLMAN CONSULTING, INC.

2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $90,000 income · posted Jul 20, 2026

View → Q1 report

MEHLMAN CONSULTING, INC.

1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $90,000 income · posted Apr 17, 2026

View → Q4 report

MEHLMAN CONSULTING, INC.

4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $90,000 income · posted Jan 16, 2026

View → Q3 report

MEHLMAN CONSULTING, INC.

3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $90,000 income · posted Oct 17, 2025

View → Q2 report

MEHLMAN CONSULTING, INC.

2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $90,000 income · posted Jul 21, 2025

View → Q1 report

MEHLMAN CONSULTING, INC.

1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $90,000 income · posted Apr 17, 2025

View →

Keep going

Filings through October 20, 2026, the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.